Alternative za pretraživanje:
doses derived » bases derived (Proširi pretraživanje), cases derived (Proširi pretraživanje), doses delivered (Proširi pretraživanje)
level theory » model theory (Proširi pretraživanje), cell theory (Proširi pretraživanje)
novel ther » novel ether (Proširi pretraživanje), novel thr (Proširi pretraživanje), novel theory (Proširi pretraživanje)
drug does » drugs does (Proširi pretraživanje), drug de (Proširi pretraživanje), drug do (Proširi pretraživanje)
drug dose » drug dosage (Proširi pretraživanje)
Prikaz rezultata 1 – 20 od 5.523 za pretraživanje '(( ((drug does) OR (drug dose)) ((novel ther) OR (level theory)) ) OR ( drug doses derived three ))', vrijeme pretraživanja: 2,56s Detaljiziraj rezultate
Biological activity of catecholamines covalently linked to synthetic polymers: proof of immobilized drug theory.
Novel Tocolytic Strategy: Modulating Cx43 Activity by S-Nitrosation

THER-03. IN VITRO EVALUATION OF THE EFFECT OF CANNABIDIOL ON PAEDIATRIC BRAIN TUMOUR CELL LINES USING A PULSED TREATMENT REGIME
Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials [version 2; referees: 2 approved, 1 approved with reservations]

Precision dosing to avoid adverse drug reactions
A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT(2B) Inverse Agonist with Preclinical Efficacy for Psychoses

THER-06. THERAPEUTIC EFFICACY OF RRV-MEDIATED PRODRUG ACTIVATOR GENE THERAPY IN CLINICAL TRIALS OF RECURRENT HIGH-GRADE GLIOMA AND IN MURINE ORTHOTOPIC MODELS OF INTRACEREBRAL GLIOMA AND INTRACEREBELLAR MEDULLOBLASTOMA
THER-22. BROMODOMAIN INHIBITORS INDUCE DOWNREGULATION OF DNA DAMAGE REPAIR PATHWAYS AND OFFER NOVEL SYNERGISTIC COMBINATIONS WITH ENHANCED SAFETY PROFILES FOR THE TREATMENT OF MEDULLOBLASTOMA AND GLIOBLASTOMA

Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers
Novel Strategies for Anterior Segment Ocular Drug Delivery

Brivaracetam: a novel antiepileptic drug for focal-onset seizures
Recent Progress in the Development of New Antimalarial Drugs with Novel Targets

Bridging the Gap between Theory and Practice; the Active Role of Inpatient Pharmacists in Therapeutic Drug Monitoring
How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti–Hepatitis B Virus Drug

Analgesic Properties of a Peripherally Acting and GalR2 Receptor–Preferring Galanin Analog in Inflammatory, Neuropathic, and Acute Pain Models
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen
The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants?

Single and multiple dose pharmacokinetics and tolerability of HX-1171, a novel antioxidant, in healthy volunteers
Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs

Alati za pretraživanje: Preuzmi RSS sažetak — Pošalji ovo pretraživanje e-poštom — Spremi pretraživanje